Hims & Hers Health earnings release, May 11, 2026

Hims & Hers Health, Inc. (HIMS) · Form 8-K, Item 2.02 · Filed · SEC filing

Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results

Revenue of approximately $608 million, up 4% year-over-year in Q1 2026

Subscribers grew to nearly 2.6 million, up 9% year-over-year in Q1 2026

Raises full year 2026 revenue guidance¹ to a range of $2.8 billion to $3.0 billion and updates Adjusted EBITDA guidance to a range of $275 million to $350 million

SAN FRANCISCO, May 11, 2026 – Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the first quarter ended March 31, 2026. Moving forward, the Company plans to transition to an annual rather than quarterly shareholder letter and will continue to provide regular updates through a quarterly earnings call, earnings release, and supplemental materials.

“2026 is a defining year for Hims & Hers. We’re not just growing, we’re pulling away from the field on our path to becoming the world’s largest consumer health platform,” said Andrew Dudum, co-founder and CEO. “As we exit the first quarter, our domestic business is accelerating, we’re expanding into new categories and countries, and more people than ever are relying on us for access to personal, data-driven care. We’re investing with conviction in comprehensive diagnostics and a technology infrastructure built to make every interaction smarter than the last. The demand for a simpler, more personal path to feeling great has never been stronger, and Hims & Hers is increasingly the answer.”

“In the first quarter, we made a strategic pivot that expanded our assortment of branded GLP-1 products, and early demand signals show our consumer reach broadening meaningfully,” said Yemi Okupe, Chief Financial Officer. “With nearly 2.6 million subscribers across a diverse breadth of specialties, we have the scale to invest in technology and operations to leverage our closed-loop ecosystem. This will allow us to elevate the subscriber experience and positions us to achieve an industry-leading cost structure. We expect growth to accelerate from here, and have high conviction in our 2030 targets of at least $6.5 billion in revenue and $1.3 billion in Adjusted EBITDA.”¹

Our second quarter and full year 2026 outlook excludes any potential contributions from the recently announced proposed acquisition of Eucalyptus, which is expected to close during the middle of calendar year 2026, subject to customary closing conditions, including regulatory approvals.

Key Business Metrics

(In Thousands, Except for Monthly Revenue per Average Subscriber, Unaudited)

Revenue

(In Thousands, Unaudited)

First Quarter 2026 Financial Highlights

• Revenue was $608.1 million for the first quarter of 2026 compared to $586.0 million for the first quarter of 2025, an increase of 4% year-over-year.

• Gross margin was 65% for the first quarter of 2026 compared to 73% for the first quarter of 2025.

• Net loss was $92.1 million for the first quarter of 2026 compared to net income of $49.5 million for the first quarter of 2025.

• Adjusted EBITDA was $44.3 million for the first quarter of 2026 compared to $91.1 million for the first quarter of 2025.

• Net cash provided by operating activities was

$89.4 million for the first quarter of 2026 compared to $109.1 million for the first quarter of 2025.

• Free Cash Flow was $53.0 million for the first quarter of 2026 compared to $50.1 million for the first quarter of 2025.

Reconciliations of Adjusted EBITDA and Free Cash Flow, non-GAAP measures, to net (loss) income and net cash provided by operating activities, respectively, their most comparable financial measures under generally accepted accounting principles in the United States (“U.S. GAAP”), have been provided in this press release in the accompanying tables. Additional information about Adjusted EBITDA and Free Cash Flow is also included below under the heading “Non-GAAP Financial Measures”.

Financial Outlook²

Hims & Hers is providing the following guidance:

For the second quarter 2026, we expect:

• Revenue of $680 million to $700 million.

• Adjusted EBITDA of $35 million to $55 million, reflecting an Adjusted EBITDA margin of 5% to 8%.

For the full year 2026, we expect:

• Revenue of $2.8 billion to $3.0 billion.

• Adjusted EBITDA of $275 million to $350 million, reflecting an Adjusted EBITDA margin of 10% to 12%.²

Our second quarter and full year 2026 outlook excludes any potential contributions from the recently announced proposed acquisition of Eucalyptus, which is expected to close during the middle of calendar year 2026, subject to customary closing conditions, including regulatory approvals.

Financial statements

Income Statement

Three Months Ended March 31, — (In Thousands, Unaudited) (in thousands)

Three Months Ended March 31, – 20252025% Change
United States Revenue529,909578,692-8.0%
Rest of the World Revenue78,1957,318969.0%
Total revenue608,104586,0104.0%

Income Statement

Three Months Ended March 31, — (In Thousands, Except Share and Per Share Data, Unaudited)

Three Months Ended March 31, – 20262025
Revenue608,104586,010
Cost of revenue211,317155,321
Gross profit396,787430,689
Gross margin %65.0%73
Operating expenses:(1)Marketing222,003231,235
Operating expenses:(1)Operations and support96,50363,033
Operating expenses:(1)Technology and development46,93629,914
Operating expenses:(1)General and administrative109,66848,610
Operating expenses:(1)Total operating expenses475,110372,792
Operating expenses:(1)(Loss) income from operations-78,32357,897
Other (expense) income:Change in fair value of equity securities-9,682
Other (expense) income:Change in fair value of liabilities-17,646
Other (expense) income:Other income, net4,1002,598
Other (expense) income:Total other (expense) income, net-23,2282,598
Other (expense) income:(Loss) income before income taxes-101,55160,495
Other (expense) income:Benefit from (provision for) income taxes9,436-11,010
Other (expense) income:Net (loss) income-92,11549,485
Other (expense) income:Other comprehensive (loss) income-6,699160
Other (expense) income:Total comprehensive (loss) income-98,81449,645
Net (loss) income per share attributable to common stockholders:Basic-0.40.22
Net (loss) income per share attributable to common stockholders:Diluted-0.40.2
Weighted average shares outstanding:Basic228,357,303221,989,327
Weighted average shares outstanding:Diluted228,357,303246,610,232

Income Statement

Three Months Ended March 31, — (In Thousands, Unaudited) (in thousands)

Three Months Ended March 31, – 20262025
Revenue608,104586,010
Net (loss) income-92,11549,485
Stock-based compensation36,86224,858
Restructuring and other related charges33,488
Depreciation and amortization21,9538,276
Change in fair value of liabilities17,646
Legal settlement costs15,000
Acquisition and transaction-related costs13,36624
Change in fair value of equity securities9,682
Payroll tax expense related to stock-based compensation2,867
Interest income and expense, net-5,033-2,596
(Benefit from) provision for income taxes-9,43611,010
Adjusted EBITDA44,28091,057
Net (loss) income as a % of revenue-158
Adjusted EBITDA margin716

Income Statement

Three Months Ended March 31, — (In Thousands, Unaudited) (in thousands)

Three Months Ended March 31, – 20262025
Revenue608,104586,010
Gross Profit396,787430,689
Restructuring and other related charges included within cost of revenue28,462
Adjusted Gross Profit425,249430,689
Gross margin %6573
Adjusted gross margin %7073

Balance Sheet

March 31, 2026 — (In Thousands, Except Share and Per Share Data, Unaudited)

March 31, 2026December 31, 2025
Current assets:Cash and cash equivalents222,266228,616
Current assets:Short-term available-for-sale investments528,609348,876
Current assets:Receivables, net149,62032,149
Current assets:Inventory79,07380,128
Current assets:Prepaid expenses and other current assets65,79577,869
Current assets:Total current assets1,045,363767,638
Current assets:Long-term available-for-sale investments351,263
Current assets:Goodwill342,838278,325
Current assets:Property, equipment, and software, net333,845311,930
Current assets:Intangible assets, net261,034196,116
Current assets:Operating lease right-of-use assets144,247137,046
Current assets:Deferred tax assets, net92,09182,707
Current assets:Other long-term assets47,62529,680
Current assets:Total assets2,267,0432,154,705
Current liabilities:Accounts payable306,865143,278
Current liabilities:Accrued liabilities90,74378,518
Current liabilities:Deferred revenue165,132127,160
Current liabilities:Earn-out payable40,09646,986
Current liabilities:Earn-out liabilities10,3623,646
Current liabilities:Operating lease liabilities5,5794,843
Current liabilities:Total current liabilities618,777404,431
Current liabilities:Convertible senior notes, net974,106972,580
Current liabilities:Operating lease liabilities152,352143,167
Current liabilities:Earn-out payable26,944
Current liabilities:Earn-out liabilities12,28753,009
Current liabilities:Deferred tax liabilities, net23,51128,856
Current liabilities:Other long-term liabilities12,89911,734
Current liabilities:Total liabilities1,820,8761,613,777
Stockholders' equity:Common stock – Class A shares, par value $0.0001, 2,750,000,000 shares authorized and 222,326,117 and 218,867,898 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively; Class V shares, par value $0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of March 31, 2026 and December 31, 20252323
Stockholders' equity:Additional paid-in capital656,436652,383
Stockholders' equity:Accumulated other comprehensive (loss) income-4,4052,294
Stockholders' equity:Accumulated deficit-205,887-113,772
Stockholders' equity:Total stockholders' equity446,167540,928
Stockholders' equity:Total liabilities and stockholders' equity2,267,0432,154,705

Cash Flow

Three Months Ended March 31, — (In Thousands, Unaudited) (in thousands)

Three Months Ended March 31, – 20262025
Net cash provided by operating activities89,356109,090
Purchases of property, equipment, and intangible assets in investing activities-29,844-55,327
Investment in website development and internal-use software in investing activities-6,480-3,711
Free Cash Flow53,03250,052
Full release

The guidance provided above constitutes forward-looking statements and actual results may differ materially. Refer to the “Cautionary Note Regarding Forward-Looking Statements” safe harbor section below for information on the factors that could cause our actual results to differ materially from these forward-looking statements.

We have relied upon the exception in Item 10(e)(1)(i)(B) of Regulation S-K and have not reconciled forward-looking Adjusted EBITDA to its most directly comparable U.S. GAAP measure, net income or loss, because we cannot predict with reasonable certainty the ultimate outcome of certain components of such reconciliations, including market-related assumptions that are not within our control, or others that may arise, without unreasonable effort. For these reasons, we are unable to assess the probable significance of the unavailable information, which could materially impact the amount of future net income or loss. See “Non-GAAP Financial Measures” for additional important information regarding Adjusted EBITDA.

Conference Call... (truncated)conference ID #1704296. A live audio webcast will be available online at investors.hims.com. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call at the same link.

About Hims & Hers Health, Inc.

Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health.

We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the Company provides access to personalized care designed for results.

For more information, please visit investors.hims.com.

Cautionary Note Regarding Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements can be identified by the use of forward-looking terminology, including the words “believes,” “estimates,” “anticipates,” “expects,” “intends,” “plans,” “assumes,” “may,” “will,” “likely,” “potential,” “projects,” “predicts,” “continue,” “goal,” “strategy,” “future,” “forecast,” “target,” “outlook,” “opportunity,” “confidence,” “foundation,” “groundwork,” or “should,” or, in each case, their negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations. Such statements include, but are not limited to, any statements relating to our financial outlook and guidance, including our mission to drive top-line revenue growth and profitability and our ability to attain our 2026 and long-term financial and operational targets; our expected future financial and business performance, including with respect to the Hims & Hers platform, our marketing campaigns, investments in innovation, the solutions accessible on our platform, the markets accessible on our platform, and our infrastructure, and the underlying assumptions with respect to the foregoing; potential strategic investments, partnerships, or collaborations, and the expected timing or outcome of any such investments, partnerships, or collaborations; statements relating to events and trends relevant to us, including with respect to our regulatory environment, financial condition, results of operations, short- and long-term business operations, objectives, strategy, and financial needs; expectations regarding our mobile applications, market acceptance, user experience, customer retention, brand development, our ability to invest and generate a return on any such investment, customer acquisition costs, operating efficiencies and leverage (including our fulfillment capabilities), the effect of any pricing decisions; changes in our product or offering mix, and the timing and market acceptance of any new products or offerings; the timing and anticipated effect of any pending or recently completed acquisitions; the success and utility of our business model; our market opportunity; our ability to scale our business and expand internationally; the growth of certain of our specialties; our ability to innovate on and expand the scope of our offerings and experiences, including through the use of diagnostics, data analytics and artificial intelligence; our ability to reinvest into the customer experience; and our ability to comply with the extensive, complex and evolving legal and regulatory requirements applicable to our business, including without limitation state and federal healthcare, privacy and consumer protection laws and regulations, and the effect or outcome of litigation or governmental actions or statements in relation to any such legal and regulatory requirements. These statements are based on management’s current expectations, but actual results may differ materially due to various factors.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, the forward-looking statements contained in this press release are based on our current expectations, assumptions, and beliefs concerning future developments and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in the Risk Factors and other sections of our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and other current and periodic reports we file from time to time with the Securities and Exchange Commission (the “Commission”).

Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. The forward-looking statements contained in this press release are made only as of May 11, 2026. We undertake no obligation (and expressly disclaim any obligation) to update or revise any forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.... (truncated)n you that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity, and developments in the industry in which we operate may differ materially from those made in or suggested by the forward-looking statements contained in reports we have filed or will file with the Commission, including our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and other current and periodic reports we file from time to time. In addition, even if our results of operations, financial condition and liquidity, and developments in the industry in which we operate are consistent with the forward-looking statements contained in such reports, those results or developments may not be indicative of results or developments in subsequent periods.

Key Business Metrics

Our consolidated revenue primarily comprises online sales of health and wellness products through our websites and mobile applications, including prescription and non-prescription products, as well as services, primarily consisting of medical consultation services, post-consultation service support, and delivery of laboratory testing results, as applicable. Our online sales are net of refunds, credits, and chargebacks, and include revenue recognition adjustments recorded pursuant to U.S. GAAP, primarily relating to deferred revenue and returns reserve. The majority of our online sales are subscription-based, where customers agree to be billed on a recurring basis to have products and services automatically delivered to them. This revenue also includes sales from customers who have made one-time purchases. Additionally, in the United States, we offer a range of health and wellness products through wholesale partners as a way of generating brand awareness with new customers in physical environments and on third-party platforms, with such revenue not considered material to our business.

“United States Revenue” represents the sales of products and services by our consolidated legal entities operating within jurisdictions located inside of the United States.

“Rest of the World Revenue” represents the sales of products and services by our consolidated legal entities operating within jurisdictions located outside of the United States.

“Subscribers” are customers who have one or more “Subscriptions” pursuant to which they have agreed to be automatically billed on a recurring basis at a defined cadence. The Subscription billing cadence is typically defined as a number of days (for example, billed every 30 days or every 90 days), which are excluded from our reporting when payment has not occurred at the contracted billing cadence. Subscribers can cancel or snooze Subscriptions in between billing periods to stop receiving additional products and/or services and can reactivate Subscriptions to continue receiving additional products and/or services. Customers who have made one-time purchases are not considered Subscribers.

“Monthly Revenue per Average Subscriber” is defined as total revenue divided by “Average Subscribers”, which amount is then further divided by the number of months in a period.

“Average Subscribers” are calculated as the sum of the Subscribers at the beginning and end of a given period divided by 2.

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Hims & Hers Health earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.